Quantcast

Latest Arthur G. James Stories

2014-05-30 10:16:03

Ohio State University Wexner Medical Center A new study has discovered how resistance develops in patients taking ibrutinib, a new and highly effective drug for the treatment of chronic lymphocytic leukemia (CLL). The study was published in the New England Journal of Medicine and led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). It identifies gene mutations that...

2014-05-28 08:32:58

The Ohio State University Comprehensive Cancer Center and Moffitt Cancer Center create ORIEN to accelerate more precise cancer treatments, diagnostics and prevention methods TAMPA, Fla. and COLUMBUS, Ohio, May 28, 2014 /PRNewswire/ -- Two of North America's leading cancer centers, Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), today announced what is likely the...

2013-06-20 23:30:02

Two clinical studies published in the New England Journal of Medicine with an accompanying editorial suggest that the novel agent ibrutinib shows real potential as a safe, effective, targeted treatment for adults with chronic lymphocytic leukemia (CLL) and for patients with mantle cell lymphoma (MCL). Both studies, co-led by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC —...

2013-02-08 14:27:40

-Triple-negative breast cancer is an aggressive form of breast cancer that has few treatment options; -This large-scale study shows that abnormal levels of small molecules called microRNA can be used to classify this malignancy into four subtypes; -The findings could lead to new ways to identify the best therapy for individual patients and to more effective therapies in the future. A new, large-scale study of triple-negative breast cancer shows that small molecules called microRNA can be...

2012-12-12 23:28:43

-People who develop chronic lymphocytic leukemia (CLL) are typically age 65 and older, but participants in CLL clinical trials are usually several years younger; -The age of CLL patients is not usually considered when determining treatment; -This study suggests that older and younger CLL patients require different therapy. Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers at the...

2012-06-12 11:44:55

-People newly diagnosed with chronic leukemia must often wait to learn if they have a faster- or slower-progressing form of the disease. -This study identified a molecular marker that quickly helps to distinguish which form a patients has. -The findings could enable patients with aggressive disease to start treatment sooner. Researchers have identified a prognostic marker in the most common form of chronic leukemia that can help to distinguish which patients should start treatment...

2012-03-12 14:15:59

Researchers have identified a molecule that helps control the severity of graft-versus-host disease, a life-threatening complication for many leukemia patients who receive a bone-marrow transplant. The study, led by researchers with the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), used an animal model and tissues from human patients to show that high levels, or over-expression, of...

2012-02-23 18:00:04

The many short pieces of mobile DNA that exist in the genome can contribute to significant biological differences between lineages of mice, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James). The movable pieces of DNA are called transposons or "jumping genes" because they can move from one chromosomal location to another. Unlike viruses,...

2012-01-03 14:52:35

A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The finding might offer a new therapy for this malignancy, which kills an estimated 549,000 people worldwide annually.   The animal study, by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) and at Mayo Clinic, focused on microRNA-221...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.